GLUCAGONOMA
Clinical trials for GLUCAGONOMA explained in plain language.
Never miss a new study
Get alerted when new GLUCAGONOMA trials appear
Sign up with your email to follow new studies for GLUCAGONOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare pancreatic tumors: Two-Drug combo shows promise
Disease control OngoingThis study tested two chemotherapy drugs—temozolomide alone or combined with capecitabine—in 144 people with advanced pancreatic neuroendocrine tumors that could not be removed by surgery. The goal was to see if the combination could delay tumor growth better than the single drug…
Matched conditions: GLUCAGONOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New scan could spot rare tumors earlier and more safely
Diagnosis OngoingThis study is testing a new type of PET/CT scan that uses a special tracer (68Ga-DOTATOC) to find neuroendocrine tumors and other related cancers. The goal is to see if this scan is safer and more sensitive than current imaging methods. About 800 people with known or suspected tu…
Matched conditions: GLUCAGONOMA
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated May 26, 2026 05:51 UTC